Inorganic Nanoparticles for Predictive Oncology of Breast Cancer
- 19 December 2008
- journal article
- Published by Informa UK Limited in Nanomedicine
- Vol. 4 (1), 83-103
- https://doi.org/10.2217/17435889.4.1.83
Abstract
Nanoparticles (NPs) and nanosized objects are being incorporated rapidly into clinical medicine and particularly into the field of medical oncology, including breast cancer. A number of novel methods for breast cancer diagnosis and treatment, which are based on NPs and other nanodevices, are now available for translation into clinical practice. Computer tomography and MRI with iron-based magnetic NPs are promising methods for radiological detection of cancers. Semiconductor fluorescent NPs (quantum dots) are being developed for simultaneous detection and localization of multiple breast cancer biomarkers, enabling the personalization of therapeutic regimens for each patient. Additionally, inorganic NPs can be conjugated with tumor-specific ligands and used for tumor-selective delivery of chemotherapeutic or hormonal agents. NPs bearing tumor-targeted antibodies and oligonucleotides for anticancer gene therapy are a novel and rapidly developing therapeutic approach in oncology. Nab-paclitaxel and liposomal anthracyclines are US FDA-approved NP-based drug-delivery systems that have demonstrated at least equivalent efficacy and decreased toxicity compared with conventional chemotherapeutic agents used in the treatment of breast cancer. This review focuses on recent applications of NPs into predictive oncology of breast cancer with an emphasis placed on the role of inorganic nanosized objects in the diagnosis and treatment of this malignancy.Keywords
This publication has 106 references indexed in Scilit:
- Biomimetic amplification of nanoparticle homing to tumorsProceedings of the National Academy of Sciences of the United States of America, 2007
- Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremityBreast Cancer Research and Treatment, 2006
- Imaging of multiple mRNA targets using quantum dot based in situ hybridization and spectral deconvolution in clinical biopsiesBiochemical and Biophysical Research Communications, 2006
- LHRH-conjugated Magnetic Iron Oxide Nanoparticles for Detection of Breast Cancer MetastasesBreast Cancer Research and Treatment, 2006
- Cellular Effect of High Doses of Silica-Coated Quantum Dot Profiled with High Throughput Gene Expression Analysis and High Content Cellomics MeasurementsNano Letters, 2006
- Sentinel Lymph Node Mapping of the Gastrointestinal Tract by Using Invisible LightAnnals of Surgical Oncology, 2006
- Medical application of functionalized magnetic nanoparticlesJournal of Bioscience and Bioengineering, 2005
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992